Sarah Boyce Avidity Biosciences, Inc. (RNA) insider trading activity

RNA Quotes by TradingView

Sarah Boyce is President and CEO of Avidity Biosciences, Inc.. Currently has a direct ownership of 234,663 shares of RNA, which is worth approximately $9.92 Million. The most recent transaction as insider was on Sep 23, 2024, when has been sold 32,880 shares (Common Stock) at a price of $44.0 per share, resulting in proceeds of $1,446,720. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 235K
14.45% 3M change
339.84% 12M change
Total Value Held $9.92 Million

Sarah Boyce Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 23 2024
SELL
Open market or private sale
$1,446,720 $44.0 p/Share
32,880 Reduced 12.29%
234,663 Common Stock
Sep 19 2024
BUY
Grant, award, or other acquisition
-
125,000 Added 29.61%
297,163 Common Stock
Aug 06 2024
SELL
Open market or private sale
$1,213,800 $43.35 p/Share
28,000 Reduced 12.01%
205,043 Common Stock
Aug 06 2024
BUY
Exercise of conversion of derivative security
$34,720 $1.24 p/Share
28,000 Added 10.73%
233,043 Common Stock
Jul 09 2024
SELL
Open market or private sale
$1,118,040 $39.93 p/Share
28,000 Reduced 12.01%
205,043 Common Stock
Jul 09 2024
BUY
Exercise of conversion of derivative security
$34,720 $1.24 p/Share
28,000 Added 10.73%
233,043 Common Stock
Jun 18 2024
SELL
Open market or private sale
$1,255,055 $39.13 p/Share
32,074 Reduced 18.37%
142,543 Common Stock
Jun 17 2024
BUY
Grant, award, or other acquisition
-
125,000 Added 37.87%
205,043 Common Stock
Jun 14 2024
SELL
Open market or private sale
$1,433,541 $40.08 p/Share
35,767 Reduced 24.19%
112,117 Common Stock
Jun 14 2024
BUY
Exercise of conversion of derivative security
$44,351 $1.24 p/Share
35,767 Added 19.48%
147,884 Common Stock
Jun 13 2024
SELL
Open market or private sale
$6,582,458 $40.08 p/Share
164,233 Reduced 59.43%
112,117 Common Stock
Jun 13 2024
BUY
Exercise of conversion of derivative security
$203,648 $1.24 p/Share
164,233 Added 37.28%
276,350 Common Stock
Jun 12 2024
SELL
Open market or private sale
$3,572,999 $35.73 p/Share
100,000 Reduced 47.14%
112,117 Common Stock
Jun 12 2024
BUY
Exercise of conversion of derivative security
$124,000 $1.24 p/Share
100,000 Added 32.04%
212,117 Common Stock
Jun 04 2024
SELL
Open market or private sale
$767,760 $27.42 p/Share
28,000 Reduced 19.98%
112,117 Common Stock
Jun 04 2024
BUY
Exercise of conversion of derivative security
$34,720 $1.24 p/Share
28,000 Added 16.66%
140,117 Common Stock
May 07 2024
SELL
Open market or private sale
$715,120 $25.54 p/Share
28,000 Reduced 19.98%
112,117 Common Stock
May 07 2024
BUY
Exercise of conversion of derivative security
$34,720 $1.24 p/Share
28,000 Added 16.66%
140,117 Common Stock
Apr 02 2024
SELL
Open market or private sale
$735,000 $26.25 p/Share
28,000 Reduced 19.98%
112,117 Common Stock
Apr 02 2024
BUY
Exercise of conversion of derivative security
$34,720 $1.24 p/Share
28,000 Added 16.66%
140,117 Common Stock
Mar 12 2024
SELL
Open market or private sale
$633,640 $22.63 p/Share
28,000 Reduced 19.98%
112,117 Common Stock
Mar 12 2024
BUY
Exercise of conversion of derivative security
$34,720 $1.24 p/Share
28,000 Added 16.66%
140,117 Common Stock
Mar 08 2024
SELL
Open market or private sale
$1,796,760 $21.39 p/Share
84,000 Reduced 42.83%
112,117 Common Stock
Mar 08 2024
BUY
Exercise of conversion of derivative security
$104,160 $1.24 p/Share
84,000 Added 29.99%
196,117 Common Stock
Mar 01 2024
SELL
Open market or private sale
$1,690,920 $20.13 p/Share
84,000 Reduced 42.83%
112,117 Common Stock

Also insider at

BLI
Berkeley Lights, Inc. Healthcare
Director
LGND
LIGAND PHARMACEUTICALS INC Healthcare
AHPAW
Avista Public Acquisition Corp. II Financial Services
Director
CTNM
Contineum Therapeutics, Inc.
Director
SB

Sarah Boyce

President and CEO
San Diego, CA

Track Institutional and Insider Activities on RNA

Follow Avidity Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNA shares.

Notify only if

Insider Trading

Get notified when an Avidity Biosciences, Inc. insider buys or sells RNA shares.

Notify only if

News

Receive news related to Avidity Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RNA